Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis.
Mateus Bringel Oliveira DuarteFrederico LealJuliana Luz Passos ArgentonJosé Barreto Campello CarvalheiraPublished in: Infectious agents and cancer (2021)
The active use of ADT was not associated with a reduced risk of death in patients with COVID-19.